LogicBio Therapeutics, Inc. Deferred Offering Costs
LogicBio Therapeutics, Inc. had Deferred Offering Costs of $0 as of 2021-12-31, per its 10-K filed 2022-03-04.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-03-04
- 2021-12-31: Deferred Offering Costs $0.00.
- 2020-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-04 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-15 |